A Validation Study of a Point-of-Care Nerve Conduction Device for the Quantitative Assesment of Chemotherapy-Induced Peripheral Neurotoxicity
Not Applicable
- Conditions
- Those who suffer from chemotherapy-induced peripheral neurotoxicity
- Registration Number
- JPRN-UMIN000016505
- Lead Sponsor
- Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with pre-existing neuropathy, diabetes mellitus, alcoholic abuse or central nervous system metastasis are excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method